Trial of Satralizumab in Neuromyelitis Optica Spectrum Disorder.
N Engl J Med. 2019 Nov 28;381(22):2114-2124. doi: 10.1056/NEJMoa1901747.
N Engl J Med. 2019.
PMID: 31774956
Clinical Trial.